Athena Global Technologies Completes Healthcare Unit Acquisition and Divestment in Corporate Restructuring
Athena Global Technologies Limited completed a corporate restructuring on March 31, 2026, involving the acquisition of 100% equity in MedleyMed Healthcare Solutions Private Limited for Rs. 10,000 and the divestment of Medley Medical Solutions Private Limited for Rs. 1.25 crores. Both related party transactions were conducted at arm's length to consolidate the group's healthcare and trading operations under one entity.

*this image is generated using AI for illustrative purposes only.
Athena Global Technologies Limited has announced the completion of a strategic corporate restructuring involving the acquisition and divestment of healthcare subsidiaries. The board of directors approved these transactions during their meeting held on March 31, 2026, aimed at consolidating the group's healthcare and trading operations.
Acquisition Details
The company has acquired 100% equity shareholding of MedleyMed Healthcare Solutions Private Limited, converting it into a wholly owned subsidiary. The acquisition represents a strategic move to strengthen the company's position in healthcare logistics and pharmaceutical trading operations.
| Parameter: | Details |
|---|---|
| Target Company: | MedleyMed Healthcare Solutions Private Limited |
| CIN: | U24239TG2019PTC136763 |
| Acquisition Cost: | Rs. 10,000 |
| Equity Stake: | 100% |
| Transaction Type: | Cash consideration |
| Completion Date: | March 31, 2026 |
MedleyMed Healthcare Solutions, incorporated on November 14, 2019, specializes in healthcare logistics and pharmaceutical trading operations. The company operates as a small-scale unit and has shown varying financial performance over recent years.
Financial Performance of Acquired Entity
The target company's turnover history demonstrates significant fluctuations in business performance:
| Financial Year: | Turnover (Lakhs) |
|---|---|
| FY-2025: | 44.18 |
| FY-2024: | 299.75 |
| FY-2023: | 299.95 |
Divestment Transaction
Simultaneously, Athena Global Technologies has divested its stake in Medley Medical Solutions Private Limited as part of the restructuring exercise. This divestment complements the acquisition strategy by streamlining the group's healthcare operations.
| Parameter: | Details |
|---|---|
| Divested Company: | Medley Medical Solutions Private Limited |
| CIN: | U93000TG2016PTC111660 |
| Sale Consideration: | Rs. 1,25,33,689 |
| Buyer: | MedleyMed Healthcare Solutions Private Limited |
| Expected Completion: | March 31, 2026 |
Financial Impact and Contribution
The divested entity's contribution to the consolidated financials as of September 30, 2025, was relatively modest:
- Income Contribution: 0.17% of total consolidation income (0.94 lakhs)
- Net Worth Contribution: 0.39% of total consolidation net worth (55.95 lakhs)
Regulatory Compliance and Structure
Both transactions qualify as related party transactions conducted at arm's length basis. The acquisition requires no specific government approvals beyond standard compliance under the Companies Act, 2013 and SEBI regulations. The restructuring aims to consolidate group healthcare and trading businesses under one entity for improved operational efficiency.
The board meeting commenced at 6:30 PM and concluded at 7:15 PM on March 31, 2026, with all necessary approvals obtained for both transactions. These strategic moves reflect the company's commitment to optimizing its healthcare business portfolio through focused consolidation.
Historical Stock Returns for Athena Global Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.21% | -0.72% | -15.44% | -31.97% | -26.95% | +77.46% |
How will Athena Global Technologies address the significant revenue decline in MedleyMed Healthcare Solutions from Rs. 299.75 lakhs in FY-2024 to Rs. 44.18 lakhs in FY-2025?
What synergies does Athena expect to achieve by consolidating its healthcare operations, and what is the projected timeline for operational integration?
Will this restructuring lead to further acquisitions in the healthcare logistics sector or expansion into new pharmaceutical trading markets?






























